CIK 0001434647 · Non-accelerated filer<br>Smaller reporting company
ZEVRA THERAPEUTICS, INC.
Sign in to watch- Ticker
- ZVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205894398
- Phone
- (888) 958-1253
- Business address
- 101 FEDERAL STREET, BOSTON, MA, 02110
- Former names
- KEMPHARM, INC, KEMPHARM INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $224,948
- in 1 filing, $225K under 10b5-1 plans
Net −$224,948. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-31 | Clifton R. LaDuane Former CFO & Treasurer | Option exercise · Performance Stock Unit | −20,000 | 0 | ||
| 2025-12-02 | Secor Alicia Director | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2025-10-10 | McFarlane Neil F. President and CEO | Option exercise 10b5-1 | +50,000 | 241,516 | ||
| 2025-10-10 | McFarlane Neil F. President and CEO | Sale 10b5-1 | −19,500 | $10.82 | $211K | 222,016 |
| 2025-10-10 | McFarlane Neil F. President and CEO | Option exercise · Restricted Stock Unit 10b5-1 | −50,000 | 100,000 | ||
| 2025-09-12 | FAVORITO TAMARA A Director | Purchase | +3,175 | $7.79 | $25K | 3,894 |
| 2025-09-12 | Shih Alvin Director | Purchase | +20,000 | $7.89 | $158K | 20,000 |
| 2025-08-19 | Bode John B Director | Purchase | +5,000 | $9.17 | $46K | 45,000 |
| 2025-06-26 | Thompson Rahsaan Chief Legal & Compliance | Sale 10b5-1 | −24,000 | $9.21 | $221K | 42,666 |
| 2025-06-21 | Thompson Rahsaan Chief Legal & Compliance | Option exercise | +66,666 | 66,666 | ||
| 2025-06-21 | Thompson Rahsaan Chief Legal & Compliance | Option exercise · Restricted Stock Unit | −66,666 | 133,334 | ||
| 2025-05-29 | Shih Alvin Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2025-05-29 | DIXON WENDY L Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2025-05-29 | Calder Douglas W Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2025-05-29 | FAVORITO TAMARA A Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2025-05-29 | Watton Corey Michael Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2025-05-29 | Bode John B Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2025-05-29 | Anderson Thomas Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2025-03-28 | Watton Corey Michael Director | Purchase | +300 | $7.84 | $2K | 1,800 |
| 2025-03-19 | Bode John B Director | Purchase | +10,000 | $7.96 | $80K | 40,000 |
Page 4 of 9 · 166 trades